Wuhan Hiteck Biological Pharma Co.,Ltd (SHE:300683)

SHE:300683 Revenue

Wuhan Hiteck Biological Pharma Co.,Ltd had revenue of 156.67M CNY in the quarter ending March 31, 2025, with 18.79% growth. This brings the company's revenue in the last twelve months to 673.76M, up 13.13% year-over-year. In the year 2024, Wuhan Hiteck Biological Pharma Co.,Ltd had annual revenue of 648.97M with 7.75% growth.

• Revenue (ttm): 673.76M
• Revenue Growth: +13.13%
• P/S Ratio: 4.89
• Revenue / Employee: 514.71K
• Employees: 1,309
• Market Cap: 3.30B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	648.97M	46.69M	7.75%
Dec 31, 2023	602.28M	-86.34M	-12.54%
Jan 1, 2023	688.63M	73.94M	12.03%
Jan 1, 2022	614.68M	90.56M	17.28%
Dec 31, 2020	524.12M	-96.04M	-15.49%